CClinicalTrials.gg
Status unknownNCT04224129NDysUpdated Jan 13, 2020

Characterization and Causative Factors of Negative Dysphotopsia

An observational study in Pseudoaphakia, sponsored by Vienna Institute for Research in Ocular Surgery. Status unknown at 1 site in Austria. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2020-01-13.

Sponsored by Vienna Institute for Research in Ocular Surgery · Observational

The sponsor has not verified this record recently (last verified Jan 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
10
Ages
21 Years and older
Sex
All
01

Study summary

The present study is designed as an exploratory study, seeking to investigate the correlation of patient complaints to subjective or objective measurement methods. Better understanding of causative factors of negative dysphotopsia will improve detection and maybe prediction of this optical phenomenon.

02

Conditions studied

  • Pseudoaphakia

Browse trials for

03

In context

Cataract

1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.

This study's planned enrollment of 10 is below the median of 81 across 484 observational studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

Vienna Institute for Research in Ocular Surgery is the lead sponsor of 64 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

10 patients after cataract extraction, suffering from negative dysphotopsia

Inclusion criteria

  • Pseudophakic
  • Recurrently and persistently reporting about negative dysphotopsia
  • Age 21 and older
  • written informed consent prior to entering the study

Exclusion criteria

Exclusion Criteria:

  • Relevant ophthalmic diseases such as: glaucoma, (previous) traumatic cataract, corneal scars, age-related macular degeneration and other pathologies resulting in visual field defects
  • Pregnancy
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
10 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Identification of factors or a combination thereof that may cause negative dysphotopsia

    Biometry, Anamnesis, visual field, psychological questionnaires, wavefront aberrometry will be used to analyse if a factor causative for negative dysphotopsia can be detected

    Time frame: 2 hours

Secondary outcomes

  1. Method to standardize characterization of negative dysphotopsia

    New approaches like Goldmann visual field are used to try to picture negative dysphotopsias and patients will also be asked to draw the "dark shadows"

    Time frame: 20 minutes

  2. Correlation between eye biometry, patient complaints and psychophysics

    Eye biometry will be measured using IOL Master 700, patient complaints will be asked during an patient-doctor interview, and psychophysics will be assessed using a psychological questionnaire

    Time frame: 30 minutes

07

Study locations

1 of 1 sites recruiting
  • Hanusch-Krankenhaus
    Vienna, A-1140, Austria
    • Oliver Findl, MD, MBA · Contact · oliver@findl.at · +431 910 21 84611
    • Oliver Findl, MD, MBA · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04224129
Lead sponsor
Vienna Institute for Research in Ocular Surgery
Responsible party
Prim. Prof. Dr. Oliver Findl, MBA (Principal Investigator, Vienna Institute for Research in Ocular Surgery) — Principal investigator
First posted
Jan 13, 2020
Start date
Jan 2016
Primary completion
Dec 2020 (estimated)
Completion
May 2021 (estimated)
Last update
Jan 13, 2020

Study contacts

Oliver Findl, MD, Prof.
Contact
office@viros.at
004319102157564
Oliver Findl, MD, Prof.
principal investigator · Vienna Institute for Research in Ocular Surgery

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion